Faculty of 1000 evaluation for Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-08-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.3410/f.725906798.793535266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Liquid biopsy enters the clinic — implementation issues and future challenges

  2021cites this paper
• EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

  2019cites this paper
• New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma

  2019cites this paper
• Liquid biopsy for pediatric central nervous system tumors

  2018cites this paper
• Real-time detection of circulating tumor cells in living animals using functionalized large gold nanorods

  2018cites this paper
• Interrogating open issues in cancer precision medicine with patient-derived xenografts

  2017cites this paper